{"id":13393,"date":"2023-05-24T14:47:17","date_gmt":"2023-05-24T14:47:17","guid":{"rendered":"https:\/\/ultimatehealthreport.com\/less-pain-fewer-opioids-after-cannabis\/"},"modified":"2023-05-24T14:47:17","modified_gmt":"2023-05-24T14:47:17","slug":"less-pain-fewer-opioids-after-cannabis","status":"publish","type":"post","link":"https:\/\/ultimatehealthreport.com\/less-pain-fewer-opioids-after-cannabis\/","title":{"rendered":"Less Pain, Fewer Opioids After Cannabis"},"content":{"rendered":"
\n<\/p>\n
Arguably the top place for cannabis research right now is in Canada, largely due to the fact that the nation currently has the best national cannabis laws on the planet. Canada is one of only three countries to have passed a national cannabis legalization measure, with the other two being Uruguay and Malta.<\/p>\n
The favorable laws, in turn, make barriers and hurdles to launching and completing research projects less daunting. Canada\u2019s cannabis consumer and patient populations are considerably larger than that of Uruguay and Malta combined, and the North American country is a wealth of cannabis-focused data, including data pertaining to medical cannabis patients and use.<\/p>\n
Researchers in Canada recently conducted a study involving cancer patients who completed medical cannabis treatments. What the study participants reported after their medical cannabis treatments is insightful. Below is more information about it via a news release from\u00a0NORML:<\/p>\n
Montreal, Canada:\u00a0<\/strong>Cannabis is associated with sustained reductions in cancer pain and\u00a0may be safely incorporated in cancer patients\u2019 treatment regimens, according to\u00a0data\u00a0published in the journal\u00a0BMJ Supportive & Palliative Care<\/em>.<\/p>\n Canadian researchers affiliated with McGill University assessed the safety and efficacy of plant-derived cannabis in 358 cancer patients. Study participants consumed cannabis as an adjunctive treatment for one year.<\/p>\n Subjects experienced statistically significant decreases in pain within three months. Patients maintained their pain relief throughout the study. Participants who consumed cannabis flower containing nearly equal percentages of THC and CBD experienced greatest relief.<\/p>\n Although some patients reported side-effects from cannabis, most of these episodes were categorized as \u201cnon-serious.\u201d Patients were most likely to report experiencing sleepiness or fatigue.<\/p>\n